Volume 73, Issue 3, Pages (March 2018)

Slides:

Advertisements

Similar presentations

Volume 60, Issue 5, Pages (November 2011)

Advertisements

The PSA Era is not Over for Prostate Cancer

Volume 72, Issue 2, Pages (August 2017)

Volume 70, Issue 5, Pages (November 2016)

Volume 64, Issue 3, Pages (September 2013)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 45, Issue 6, Pages (June 2004)

Global Trends in Testicular Cancer Incidence and Mortality

Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer Marisa Warmuth,

Volume 53, Issue 4, Pages (April 2008)

Volume 70, Issue 1, Pages (July 2016)

Volume 73, Issue 1, Pages (January 2018)

EAU Guidelines on Surgical Treatment of Urinary Incontinence

Volume 67, Issue 4, Pages (April 2015)

Volume 67, Issue 3, Pages (March 2015)

Volume 72, Issue 5, Pages (November 2017)

Volume 61, Issue 5, Pages (May 2012)

Volume 58, Issue 5, Pages (November 2010)

Volume 69, Issue 1, Pages (January 2016)

Volume 73, Issue 1, Pages (January 2018)

EAU Guidelines on Testicular Cancer: 2011 Update

Volume 71, Issue 4, Pages (April 2017)

Volume 64, Issue 4, Pages (October 2013)

Volume 63, Issue 1, Pages (January 2013)

Volume 64, Issue 4, Pages (October 2013)

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 54, Issue 4, Pages (October 2008)

Volume 73, Issue 2, Pages (February 2018)

Volume 51, Issue 3, Pages (March 2007)

Volume 71, Issue 3, Pages (March 2017)

Volume 70, Issue 3, Pages (September 2016)

Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance Adam B. Weiner, Ruth Etzioni, Scott E. Eggener

Volume 65, Issue 2, Pages (February 2014)

Volume 68, Issue 3, Pages (September 2015)

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Contemporary Management of Postchemotherapy Testis Cancer

Volume 64, Issue 3, Pages (September 2013)

The PSA Era is not Over for Prostate Cancer

Yuanshan Cui, Yong Zhang European Urology

Volume 72, Issue 1, Pages (July 2017)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 53, Issue 4, Pages (April 2008)

Volume 63, Issue 3, Pages (March 2013)

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Volume 63, Issue 3, Pages (March 2013)

Volume 64, Issue 1, Pages (July 2013)

Volume 52, Issue 1, Pages (July 2007)

Karl-Dietrich Sievert, Bastian Amend, Arnulf Stenzl European Urology

Prostate-Specific Antigen Kinetics and Outcomes in Patients with Bone Metastases from Castration-Resistant Prostate Cancer Treated with or Without Zoledronic.

Volume 62, Issue 6, Pages (December 2012)

Volume 72, Issue 2, Pages (August 2017)

Volume 72, Issue 6, Pages (December 2017)

Volume 50, Issue 5, Pages (November 2006)

Single-Incision Mini-Slings Versus Standard Midurethral Slings in Surgical Management of Female Stress Urinary Incontinence: A Meta-Analysis of Effectiveness.

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Volume 71, Issue 2, Pages (February 2017)

Volume 71, Issue 5, Pages (May 2017)

Volume 73, Issue 2, Pages (February 2018)

Testicular Cancer Variations in Time and Space in Europe

The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.

Long-Term Hormonal Therapy: Who Would Benefit?

Prognostic Impact of Comorbidity in Patients with Bladder Cancer

How and When to Take Prostate Biopsies

Volume 71, Issue 3, Pages (March 2017)

European Urology is “Your” Journal

Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature Liliana Vartolomei, Shahrokh F. Shariat, Mihai.

Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer Sten Holmäng European Urology.

Penile and Testicular Cancer: What's New in 2006?

Volume 54, Issue 1, Pages (July 2008)

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Volume 73, Issue 3, Pages 394-405 (March 2018) Testicular Tumour Size and Rete Testis Invasion as Prognostic Factors for the Risk of Relapse of Clinical Stage I Seminoma Testis Patients Under Surveillance: a Systematic Review by the Testicular Cancer Guidelines Panel Joost L. Boormans, Javier Mayor de Castro, Lorenzo Marconi, Yuhong Yuan, M. Pilar Laguna Pes, Carsten Bokemeyer, Nicola Nicolai, Ferran Algaba, Jan Oldenburg, Peter Albers European Urology Volume 73, Issue 3, Pages 394-405 (March 2018) DOI: 10.1016/j.eururo.2017.09.025 Copyright © 2017 European Association of Urology Terms and Conditions

Fig. 1 PRISMA flow diagram of the study. PF=prognostic factor. European Urology 2018 73, 394-405DOI: (10.1016/j.eururo.2017.09.025) Copyright © 2017 European Association of Urology Terms and Conditions

Fig. 2 Simple Forest plot showing the relapse rate for CS I seminoma testis patients managed by surveillance having a tumour size of ≤4 versus >4cm. CS I=clinical stage I; M–H=Mantel-Haenszel; CI=confidence interval; RTI=rete testis invasion. European Urology 2018 73, 394-405DOI: (10.1016/j.eururo.2017.09.025) Copyright © 2017 European Association of Urology Terms and Conditions

Fig. 3 Simple Forest plot showing the relapse rate for CS I seminoma testis patients managed by surveillance in the presence versus the absence of rete testis invasion. CS I=clinical stage I; M–H=Mantel–Haenszel; CI=confidence interval. European Urology 2018 73, 394-405DOI: (10.1016/j.eururo.2017.09.025) Copyright © 2017 European Association of Urology Terms and Conditions